Tigo Energy to Unveil Integrated Solar-Plus-Storage Solution for Iberian Market at Genera Energy and Environment Fair
16.2.2023 09:00:00 EET | Business Wire | Press release
Tigo Energy, Inc. (“Tigo” or the “Company”), a leading provider of intelligent solar and energy storage solutions, will showcase and launch the Tigo EI Residential Solar Solution to the Iberian market at the Genera Energy and Environment Fair in Madrid on Wednesday, February 22, 2023. Tigo business and engineering representatives will attend the conference to meet with Spanish PV professionals and to show them the peculiarities of the new Tigo all-in-one system.
The Tigo EI Residential Solar Solution for the European market consists of Tigo TS4 Flex MLPE products, a new line of single-phase and three-phase inverters, modular DC-coupled energy storage components, and the Tigo EI Link, which acts as the communications hub and central connection point for all grid, inverter, PV, and battery connections. Through module-level monitoring, energy data from the EI Residential Storage System is processed by Tigo Energy Intelligence software, allowing installers to monitor and manage their fleet of customer systems with a few mouse clicks. Tigo customers in the EU will also benefit from industry-leading warranties and a skilled, multilingual support team to ensure that installers are never on their own with Tigo products.
“The solar market in Spain is expanding rapidly, in terms of installed PV capacity as well as residential sector installs, so Tigo’s release of the EI Residential Solution here could not be timed more perfectly,” said Pablo Campo Martínez, CEO at DSP Solar. “What makes Tigo so beneficial in the eyes of Spanish installers is the modular and scalable architecture: fast installations and smooth commissioning means more running systems, all managed with a user-friendly monitoring platform characterized by absolute data granularity.”
Genera Energy and Environment Fair attendees can learn about the EI Residential Solution by attending one of a series of presentations during the conference. These sessions include participation by Tigo engineers and will be hosted by Grupo Noria (Tuesday, February 21 at 15:00, Wednesday, February 22 at 11:00, and Thursday, February 23 at 15:00 in booth 8-8B04) and by DSP Solar (Wednesday, February 22 at 16:30 in booth 8-8D15).
“Every aspect of the installation process of the EI Residential Solution is shaped around the installer, combining the simplicity of a plug-and-play system with a streamlined process, from installation to commissioning,” said Ángel Marrero, renewables product manager at Grupo Noria. “With a stackable architecture, the EI solution brilliantly solves the problem related to space constraints faced by our residential customers. For us as installers, the EI Solution provides detailed remote monitoring with powerful software to make operations and maintenance very efficient. Finally, Tigo’s Reclaimed Energy technology is a powerful tool to maximize return on investment and quantify the benefits of optimization in all kinds of PV installations, which benefits installers as well as homeowners.”
In addition to an introduction to the new Tigo EI Residential Solution, Genera attendees can also learn more about the Tigo TS4 Flex MLPE platform. Company representatives will also participate in two panel discussions about the benefits of optimization on commercial and industrial (C&I) solar, which are scheduled to take place on Thursday, February 23 at 11:00 at the Technosun booth (8-8B22) and again at 13:00 at the Albasolar booth (nr 10-10G37). Both discussions will be moderated by Gianluca Pieralli, the Tigo Business Development Manager Iberia and Large Project Coordinator.
To learn more about the Tigo Flex MLPE product family and the Tigo EI Residential Solar Solution, please visit the Genera International Energy and Environment Fair (Ifema, Madrid) from February 21 to 23, 2023. To view a list of partners showcasing Tigo solutions or schedule an appointment with a Tigo representative ahead of time, please visit the Tigo scheduling page here.
About Tigo Energy
Founded in 2007, Tigo is a worldwide leader in the development and manufacture of smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Tigo combines its Flex MLPE (Module Level Power Electronics) and solar optimizer technology with intelligent, cloud-based software capabilities for advanced energy monitoring and control. Tigo MLPE products maximize performance, enable real-time energy monitoring, and provide code-required rapid shutdown at the module level. The company also develops and manufactures products such as inverters and battery storage systems for the residential solar-plus-storage market. For more information, please visit www.tigoenergy.com.
About DSP Solar
Founded in 2007, DSP Solar was born from the commitment with the society and the environment, given the incipient climate change. More than a decade later, many professionals in the sector guide their knowledge and good practices under the protection of the maximum “closeness and trust” to the personalized advice of each client, together with the after-sales technical service has led it to become a benchmark in the sector with a portfolio of more than 10,000 professional clients and 1 million items sold as of 2022.
About Grupo Noria
Grupo Noria is the purchasing center that provides service to a group of brands dedicated to the purchase, sale and distribution of electrical, climate, plumbing, telecommunications and renewable material. Among its associates, up to now, there are three outstanding brands: Novelec, Sinelec and Muntaner Electro. The main objective of Grupo Noria is to collaborate with its clients in improving their business processes, offering them a personalized service of the highest quality. The constant search for new and innovative solutions has led the company to offer a continuous improvement of its services, supporting lighting projects, air conditioning, home automation, automation, fluids, pipes, conductors, energy efficiency and VDI networks. The group was formalized in 2013 and has professionals with extensive experience in this sector. Today it works with an ambitious agenda to accelerate its growth, new commitments and entry into new markets. At the beginning of 2022, he joined UNEF as a result of its strategy of commitment to renewable energies. Grupo Noria has a dedicated team and resources that allow it to manage the service to its customers faster.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005912/en/
Contact information
Gilberto Lembo
EMEA Marketing Manager at Tigo Energy
marketing@tigoenergy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
